| 21/03 | Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy.. | BU |
| 21/03 | Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert.. | AQ |
| 17/03 | FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's .. | AQ |
| 16/03 | Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid | AQ |
| 16/03 | 19 pill Paxlovid moves closer to full FDA approval | AQ |
| 16/03 | 19 pill Paxlovid moves closer to full FDA approval | AQ |
| 16/03 | FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's .. | BU |
| 16/03 | Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Includi.. | AQ |
| 16/03 | Pfizer : 2022 ESG Report | PU |
| 16/03 | Laos, Malawi, Rwanda and Zambia Have Received Oral Antiviral Treatments for High-Risk P.. | AQ |
| 16/03 | Fitch Revises Pfizer's Outlook to Stable; Affirms IDR at 'A' | AQ |
| 16/03 | Pfizer acquires Seagen for 43 billion USD | AQ |
| 15/03 | FDA panel to consider full approval of Pfizer's COVID-19 drug Paxlovid | AQ |
| 15/03 | In The Queue : AcurX Pharmaceuticals Earnings...Here's What Investors Need To Know Before .. | AQ |
| 14/03 | Astellas Announces Phase 3 China ARCHES Study of XTANDI Meets Primary Endpoint | AQ |
| 14/03 | Pfizer to acquire Seagen for $43 billion | AQ |
| 14/03 | Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead.. | AQ |
| 13/03 | Pfizer pays $43 billion to buy cancer-fighting biotech company Seagen | AQ |
| 13/03 | Pfizer buys Seagen for $43B, boosts access to cancer drugs | AQ |
| 13/03 | Pfizer's ZAVZPRET Migraine Nasal Spray Receives FDA Approval | AQ |
| 13/03 | Pfizer Inc : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other E.. | AQ |
| 13/03 | Pfizer : Press Release | PU |
| 13/03 | Pfizer Invests $43 Billion to Battle Cancer | BU |
| 13/03 | Pfizer Invests $43 Billion to Battle Cancer | BU |
| 10/03 | FDA approves Pfizer's nasal spray zavegepant for migraines | AQ |
| 10/03 | Pfizer's ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval | BU |
| 07/03 | Mainz Biomed In Focus Ahead Of Two Data-Set Releases In 1H/2023 ($MYNZ) | AQ |
| 06/03 | Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma | AQ |
| 03/03 | Keeping IP Under Lock And Key | AQ |
| 03/03 | Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma | AQ |
| 01/03 | DelveInsight Evaluates a Robust Oligodendroglioma Pipeline as 10+ Influential Pharma Pl.. | AQ |
| 28/02 | FDA panel narrowly backs Pfizer RSV vaccine for older adults | AQ |
| 28/02 | Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for.. | BU |
| 28/02 | Mainz Biomed's Milestones Reached In 2022 Can Be Catalysts In 1/H 2023...Here's Why ($M.. | AQ |
| 27/02 | Brazil Covid Vaccine | AQ |
| 27/02 | Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare .. | BU |
| 23/02 | PFIZER INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
.. | AQ |
| 23/02 | Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance | AQ |
| 23/02 | New booster plan in time for winter | AQ |
| 22/02 | U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus.. | AQ |
| 22/02 | Genentech BPCIA Trastuzumab Case Against Tanvez Dismissed After Settlement | AQ |
| 22/02 | Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance | BU |
| 21/02 | Pfizer : 8-K Feb 21 2023 - Form 8-K | PU |
| 21/02 | Pfizer Inc : Other Events (form 8-K) | AQ |
| 21/02 | FDA weighing approval for RSV vaccine for infants, will decide this summer | AQ |
| 21/02 | Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness.. | AQ |
| 21/02 | Race To The Cure : Here's Why Acurx Pharmaceuticals Could Win The Battle To Treat C. diffi.. | AQ |
| 21/02 | U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus.. | BU |
| 20/02 | Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme disease Vacci.. | AQ |
| 17/02 | NHI Bill Must Still Clear Many Hurdles to Ensure Adequate Medicine Access | AQ |
| 17/02 | Pfizer Announces Positive TALZENNA and XTANDI Combination Data from Phase 3 TALAPRO-2 S.. | AQ |
| 17/02 | Bristol Myers Squibb - Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Camp.. | AQ |
| 16/02 | Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2.. | BU |
| 16/02 | Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the.. | BU |
| 13/02 | FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO | AQ |
| 13/02 | Pfizer and BioNTech mRNA shingles vaccine study begins | AQ |
| 13/02 | Lucy Scientific Discovery, Inc.'s Health Canada License Accelerates Mission To Make Psy.. | AQ |
| 10/02 | FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib) | BU |
| 10/02 | Lucy Scientific Discovery, Inc. - A NASDAQ Listed Psychedelics-Based Therapeutics Compa.. | AQ |
| 09/02 | Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conferenc.. | BU |
| 09/02 | Awakn Life Sciences Corp Shares Rally 77% After Earning ILAP Expedited Approval Pathway.. | AQ |
| 09/02 | Supreme Court Denies Review Of Cost Sharing Assistance Program | AQ |
| 07/02 | Awakn Life Sciences Corp Earns Global AUD Treatment Interest With A New Class Of Psyche.. | AQ |
| 02/02 | Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose .. | AQ |
| 01/02 | First To File : Issue 9 | AQ |
| 01/02 | MassBio - Pfizer Pharma Day to ignite breakthrough partnerships | AQ |
| 31/01 | Drugmaker Pfizer starts low with 2023 earnings forecast | AQ |
| 31/01 | Pfizer : Q4 Earnings Snapshot | AQ |
| 31/01 | With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Break.. | AQ |
| 31/01 | Pfizer : Fourth Quarter 2022 Press Release | PU |
| 31/01 | Pfizer reports record full-year 2022 results and provides full-year 2023 financial guid.. | BU |
| 27/01 | FDA's advisers back plan to simplify COVID-19 vaccinations | AQ |
| 24/01 | Avalon GloboCare Strengthens IP Portfolio, Earns Breakthrough Patent For QTY-Code Techn.. | AQ |
| 24/01 | Avalon GloboCare Scores Patent For Breakthrough QTY-Code Technology To Expedite Develop.. | AQ |
| 19/01 | Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potenti.. | AQ |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
